Lyra Therapeutics, INC. (LYRA) — DEF 14A Filings
All DEF 14A filings from Lyra Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Lyra Therapeutics Files Definitive Proxy Statement
— Apr 4, 2025 Risk: medium
Lyra Therapeutics, Inc. filed its definitive proxy statement on April 4, 2025, for its annual meeting of stockholders. The filing details information regarding -
Lyra Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 29, 2024 Risk: low
Lyra Therapeutics, Inc. (LYRA) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. Lyra Therapeutics, Inc. will hold its 2024 Annual Meeting of St
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX